CCCC
Price
$1.44
Change
-$0.11 (-7.14%)
Updated
Jun 5, 11:00 AM (EDT)
Capitalization
109.35M
62 days until earnings call
VRTX
Price
$439.70
Change
-$6.15 (-1.38%)
Updated
Jun 5, 10:46 AM (EDT)
Capitalization
114.49B
56 days until earnings call
Interact to see
Advertisement

CCCC vs VRTX

Header iconCCCC vs VRTX Comparison
Open Charts CCCC vs VRTXBanner chart's image
C4 Therapeutics
Price$1.44
Change-$0.11 (-7.14%)
Volume$3.43K
Capitalization109.35M
Vertex Pharmaceuticals
Price$439.70
Change-$6.15 (-1.38%)
Volume$2.39K
Capitalization114.49B
CCCC vs VRTX Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. VRTX commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and VRTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (CCCC: $1.54 vs. VRTX: $445.85)
Brand notoriety: CCCC and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 51% vs. VRTX: 44%
Market capitalization -- CCCC: $109.35M vs. VRTX: $114.49B
CCCC [@Biotechnology] is valued at $109.35M. VRTX’s [@Biotechnology] market capitalization is $114.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 2 bearish.
  • VRTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than VRTX.

Price Growth

CCCC (@Biotechnology) experienced а +18.46% price change this week, while VRTX (@Biotechnology) price change was +0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.85%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

VRTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($114B) has a higher market cap than CCCC($109M). VRTX YTD gains are higher at: 10.715 vs. CCCC (-57.222). VRTX has higher annual earnings (EBITDA): -74.9M vs. CCCC (-102.74M). VRTX has more cash in the bank: 6.2B vs. CCCC (215M). CCCC has less debt than VRTX: CCCC (64.4M) vs VRTX (1.65B). VRTX has higher revenues than CCCC: VRTX (11.1B) vs CCCC (39.8M).
CCCCVRTXCCCC / VRTX
Capitalization109M114B0%
EBITDA-102.74M-74.9M137%
Gain YTD-57.22210.715-534%
P/E RatioN/A32.76-
Revenue39.8M11.1B0%
Total Cash215M6.2B3%
Total Debt64.4M1.65B4%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCVRTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
44%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
59%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 15 days ago
44%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTGHY3.300.23
+7.49%
Life Healthcare Group Holdings Ltd
SAUHY12.85-0.07
-0.54%
Straumann Holding AG
BNPQY43.79-0.28
-0.65%
BNP Paribas
NHYDY5.42-0.06
-1.09%
Norsk Hydro ASA
SNRG0.02-0.01
-31.33%
Susglobal Energy Corp.

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with KRYS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-0.14%
KRYS - VRTX
47%
Loosely correlated
+0.86%
TECH - VRTX
40%
Loosely correlated
+2.19%
IDYA - VRTX
40%
Loosely correlated
-2.50%
CCCC - VRTX
39%
Loosely correlated
+4.05%
SNDX - VRTX
39%
Loosely correlated
-2.10%
More